BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26839163)

  • 1. Quantum dots-based double imaging combined with organic dye imaging to establish an automatic computerized method for cancer Ki67 measurement.
    Wang LW; Qu AP; Liu WL; Chen JM; Yuan JP; Wu H; Li Y; Liu J
    Sci Rep; 2016 Feb; 6():20564. PubMed ID: 26839163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantum dots-based quantitative and in situ multiple imaging on ki67 and cytokeratin to improve ki67 assessment in breast cancer.
    Yuan JP; Wang LW; Qu AP; Chen JM; Xiang QM; Chen C; Sun SR; Pang DW; Liu J; Li Y
    PLoS One; 2015; 10(4):e0122734. PubMed ID: 25856425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantum dot-based multispectral fluorescent imaging to quantitatively study co-expressions of Ki67 and HER2 in breast cancer.
    Xiang QM; Wang LW; Yuan JP; Chen JM; Yang F; Li Y
    Exp Mol Pathol; 2015 Aug; 99(1):133-8. PubMed ID: 26102249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferation assessment in breast carcinomas using digital image analysis based on virtual Ki67/cytokeratin double staining.
    Røge R; Riber-Hansen R; Nielsen S; Vyberg M
    Breast Cancer Res Treat; 2016 Jul; 158(1):11-19. PubMed ID: 27283833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digital image analysis of Ki67 proliferation index in breast cancer using virtual dual staining on whole tissue sections: clinical validation and inter-platform agreement.
    Koopman T; Buikema HJ; Hollema H; de Bock GH; van der Vegt B
    Breast Cancer Res Treat; 2018 May; 169(1):33-42. PubMed ID: 29349710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality assessment of Ki67 staining using cell line proliferation index and stain intensity features.
    Lanng MB; Møller CB; Andersen AH; Pálsdóttir ÁA; Røge R; Østergaard LR; Jørgensen AS
    Cytometry A; 2019 Apr; 95(4):381-388. PubMed ID: 30556331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ki67 nuclei detection and ki67-index estimation: a novel automatic approach based on human vision modeling.
    Barricelli BR; Casiraghi E; Gliozzo J; Huber V; Leone BE; Rizzi A; Vergani B
    BMC Bioinformatics; 2019 Dec; 20(1):733. PubMed ID: 31881821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantum dot-based molecular imaging of cancer cell growth using a clone formation assay.
    Geng XF; Fang M; Liu SP; Li Y
    Mol Med Rep; 2016 Oct; 14(4):3007-12. PubMed ID: 27572664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution pattern of the Ki67 labelling index in breast cancer and its implications for choosing cut-off values.
    Cserni G; Vörös A; Liepniece-Karele I; Bianchi S; Vezzosi V; Grabau D; Sapino A; Castellano I; Regitnig P; Foschini MP; Zolota V; Varga Z; Figueiredo P; Decker T; Focke C; Kulka J; Kaya H; Reiner-Concin A; Amendoeira I; Callagy G; Caffrey E; Wesseling J; Wells C
    Breast; 2014 Jun; 23(3):259-63. PubMed ID: 24613255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ki67 and proliferation in breast cancer.
    Pathmanathan N; Balleine RL
    J Clin Pathol; 2013 Jun; 66(6):512-6. PubMed ID: 23436927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between Ki67 labeling index determined using image analysis software with virtual slide system and that determined visually in breast cancer.
    Maeda I; Abe K; Koizumi H; Nakajima C; Tajima S; Aoki H; Tsuchiya J; Tsuchiya S; Tsuchiya K; Shimo A; Tsugawa K; Ueno T; Tatsunami S; Takagi M
    Breast Cancer; 2016 Sep; 23(5):745-51. PubMed ID: 26271611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automated characterization and counting of Ki-67 protein for breast cancer prognosis: A quantitative immunohistochemistry approach.
    Mungle T; Tewary S; Arun I; Basak B; Agarwal S; Ahmed R; Chatterjee S; Maity AK; Chakraborty C
    Comput Methods Programs Biomed; 2017 Feb; 139():149-161. PubMed ID: 28187885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visual assessment of Ki67 using a 5-grade scale (Eye-5) is easy and practical to classify breast cancer subtypes with high reproducibility.
    Hida AI; Bando K; Sugita A; Maeda T; Ueda N; Matsukage S; Nakanishi M; Kito K; Miyazaki T; Ohtsuki Y; Oshiro Y; Inoue H; Kawaguchi H; Yamashita N; Aogi K; Moriya T
    J Clin Pathol; 2015 May; 68(5):356-61. PubMed ID: 25673730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative tumor heterogeneity assessment on a nuclear population basis.
    Wessel Lindberg AS; Conradsen K; Larsen R; Friis Lippert M; Røge R; Vyberg M
    Cytometry A; 2017 Jun; 91(6):574-584. PubMed ID: 28141908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical relevance of Ki67 gene expression analysis using formalin-fixed paraffin-embedded breast cancer specimens.
    Yamamoto S; Ibusuki M; Yamamoto Y; Fu P; Fujiwara S; Murakami K; Iwase H
    Breast Cancer; 2013 Jul; 20(3):262-70. PubMed ID: 22362219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Objective quantification of the Ki67 proliferative index in neuroendocrine tumors of the gastroenteropancreatic system: a comparison of digital image analysis with manual methods.
    Tang LH; Gonen M; Hedvat C; Modlin IM; Klimstra DS
    Am J Surg Pathol; 2012 Dec; 36(12):1761-70. PubMed ID: 23026928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between the Ki67 index and its area based approximation in breast cancer.
    Niazi MKK; Senaras C; Pennell M; Arole V; Tozbikian G; Gurcan MN
    BMC Cancer; 2018 Sep; 18(1):867. PubMed ID: 30176814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effect of different techniques for measurement of Ki67 proliferation on reproducibility and prognosis prediction accuracy in breast cancer.
    Gudlaugsson E; Skaland I; Janssen EA; Smaaland R; Shao Z; Malpica A; Voorhorst F; Baak JP
    Histopathology; 2012 Dec; 61(6):1134-44. PubMed ID: 22963617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the bioconjugation efficiency of different quantum dots as probes for immunostaining tumor-marker proteins.
    Xu H; Chen C; Peng J; Tang HW; Liu CM; He Y; Chen ZZ; Li Y; Zhang ZL; Pang DW
    Appl Spectrosc; 2010 Aug; 64(8):847-52. PubMed ID: 20719046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application prospective of nanoprobes with MRI and FI dual-modality imaging on breast cancer stem cells in tumor.
    Chen H; Wang Y; Wang T; Shi D; Sun Z; Xia C; Wang B
    J Nanobiotechnology; 2016 Jun; 14(1):52. PubMed ID: 27339420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.